Form 4: Paychex Director Pamela Joseph Reports Acquisition of Restricted Stock Units and Stock Options
Insider Transaction Report
Paychex Inc. Director Pamela A. Joseph has reported the acquisition of 164 restricted stock units and 670 stock options, signaling continued equity participation in the company.
Summary
- Pamela A. Joseph, a Director of Paychex Inc. (PAYX), acquired 164 shares of common stock on July 15, 2025, as an award of restricted stock units (RSUs) with a price of $0, subject to vesting pursuant to the Amended and Restated 2002 Stock Incentive Plan.
- Following this transaction, Pamela A. Joseph beneficially owns 11,045 shares of common stock.
- On the same date, July 15, 2025, Pamela A. Joseph also acquired 670 stock options with an exercise price of $140.68 per share.
- These newly acquired stock options become exercisable on July 15, 2026, and expire on July 14, 2035.
- Pamela A. Joseph holds additional stock options from previous grants, with exercise prices ranging from $70.37 to $121.63 and expiration dates between July 11, 2028, and July 14, 2034.
- A Limited Power of Attorney, dated August 1, 2024, designates Prabha S. Bhandari and Robert L. Schrader as attorneys-in-fact for Pamela A. Joseph to handle her Section 16 reporting obligations for Paychex, Inc. securities.
Sentiment
Score: 7
Explanation: The acquisition of additional equity by a director, even if through awards, generally signals confidence in the company's future performance and aligns management interests with shareholders. There are no negative disclosures.
Positives
- The acquisition of restricted stock units and stock options by a director indicates continued alignment of management interests with shareholder value.
- The awards are part of an existing stock incentive plan, suggesting a structured approach to executive compensation and retention.
Future Outlook
This filing does not contain forward-looking statements or guidance. It is a disclosure of past and current insider transactions.
Industry Context
This is a routine insider transaction filing and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Pamela A. Joseph granted a Limited Power of Attorney to Prabha S. Bhandari and Robert L. Schrader to handle her Section 16 reporting obligations for Paychex, Inc. securities. | 2024-08-01 | Streamlines compliance with SEC reporting requirements for insider transactions, ensuring timely and accurate filings on behalf of the director. |
Stakeholder Impact
- Shareholders: The acquisition of equity by a director may be viewed positively as it aligns the director's financial interests with those of the shareholders.
- Employees: The stock incentive plan mentioned (Amended and Restated 2002 Stock Incentive Plan) suggests a framework for employee and director equity participation, which can be a positive for retention and motivation.
Next Steps
- The newly acquired restricted stock units are subject to vesting.
- The newly acquired stock options will become exercisable on July 15, 2026.
Key Dates
| Date | Description |
|---|---|
| 2019-07-12 | Date exercisable for 10,801 stock options with an exercise price of $70.37. |
| 2020-07-11 | Date exercisable for 7,929 stock options with an exercise price of $85.33. |
| 2021-07-15 | Date exercisable for 5,793 stock options with an exercise price of $73.53. |
| 2022-07-15 | Date exercisable for 5,075 stock options with an exercise price of $112.67. |
| 2023-07-15 | Date exercisable for 3,027 stock options with an exercise price of $115. |
| 2024-07-15 | Date exercisable for 3,382 stock options with an exercise price of $120.86. |
| 2024-08-01 | Date of Limited Power of Attorney granted by Pamela A. Joseph to Prabha S. Bhandari and Robert L. Schrader for Section 16 reporting obligations. |
| 2025-07-15 | Transaction date for the acquisition of 164 restricted stock units and 670 stock options. |
| 2025-07-15 | Date exercisable for 3,351 stock options with an exercise price of $121.63. |
| 2025-07-17 | Signature date of the Form 4 filing by attorney-in-fact. |
| 2026-07-15 | Date exercisable for the newly acquired 670 stock options. |
| 2026-10-28 | Expiration date of Notary Public commission for Dana L. Bolia. |
| 2028-07-11 | Expiration date for 10,801 stock options with an exercise price of $70.37. |
| 2029-07-10 | Expiration date for 7,929 stock options with an exercise price of $85.33. |
| 2030-07-14 | Expiration date for 5,793 stock options with an exercise price of $73.53. |
| 2031-07-14 | Expiration date for 5,075 stock options with an exercise price of $112.67. |
| 2032-07-14 | Expiration date for 3,027 stock options with an exercise price of $115. |
| 2033-07-14 | Expiration date for 3,382 stock options with an exercise price of $120.86. |
| 2034-07-14 | Expiration date for 3,351 stock options with an exercise price of $121.63. |
| 2035-07-14 | Expiration date for the newly acquired 670 stock options. |
Recommendation
holdKeywords
Paychex, PAYX, SEC Form 4, Insider Trading, Restricted Stock Units, Stock Options, Director Compensation, Equity Award, Section 16, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.